BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2496352)

  • 21. The influence of aluminium on parathyroid hormone levels in haemodialysis patients.
    Cannata JB; Briggs JD; Junor BJ; Beastall G; Fell GS
    Proc Eur Dial Transplant Assoc; 1983; 19():244-7. PubMed ID: 6878239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
    Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomous hyperparathyroidism not associated with increased aluminum absorption.
    Mocan MZ; Mocan H; Fell GS; Junor BJ; Boyce BF
    Isr J Med Sci; 1992 Jan; 28(1):24-6. PubMed ID: 1733894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.
    Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Togawa A; Hishida A; Uchida E; Akizawa T; Koshikawa S
    Br J Clin Pharmacol; 2004 Jun; 57(6):726-34. PubMed ID: 15151518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation.
    Ali AA; Varghese Z; Moorhead JF; Baillod RA; Sweny P
    Clin Nephrol; 1993 Apr; 39(4):205-9. PubMed ID: 8491050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial.
    Basile C; Libutti P; Di Turo AL; Vernaglione L; Casucci F; Losurdo N; Teutonico A; Lomonte C
    Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intact parathyroid hormone, ionized calcium and calcium infusion test in the evaluation of hyperparathyroidism in chronic renal failure.
    Pietilä K; Mörsky P; Pasternack A; Mustonen J; Koivula T
    Nephron; 1987; 47(4):284-9. PubMed ID: 3696331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
    Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
    Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in intact parathyroid hormone levels during hemodialysis following exposure to either differing dialyzate calcium concentrations or calcium-free dialysis with varying calcium infusion rates.
    Kaye M; Fischer D
    Clin Nephrol; 1990 Aug; 34(2):84-7. PubMed ID: 2225558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of calcium balance in patients on hemodialysis, based on ionized calcium and parathyroid hormone responses.
    Bech A; Reichert L; Telting D; de Boer H
    J Nephrol; 2013; 26(5):925-30. PubMed ID: 23475464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous 1,25(OH)2 vitamin D3 therapy in haemodialysis patients: evaluation of direct and calcium-mediated short-term effects on serum parathyroid hormone concentration.
    Probst W; Fischer JA; Binswanger U
    Nephrol Dial Transplant; 1990; 5(6):457-60. PubMed ID: 2122324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia].
    Djerad M; Morinière P; Westeel PF; el Esper N; Boitte F; Morsli R; Schenouda M; Compagnon M; Achard JM; Fournier A
    Nephrologie; 1991; 12(4):193-7. PubMed ID: 1745337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of direction and rate of change of calcium on parathyroid hormone secretion in uraemia.
    Cunningham J; Altmann P; Gleed JH; Butter KC; Marsh FP; O'Riordan JL
    Nephrol Dial Transplant; 1989; 4(5):339-44. PubMed ID: 2505183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
    De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
    Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
    Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
    D'Amour P; Palardy J; Bahsali G; Mallette LE; DeLéan A; Lepage R
    J Clin Endocrinol Metab; 1992 Mar; 74(3):525-32. PubMed ID: 1740486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aluminium hydroxide on serum ionised calcium, immunoreactive parathyroid hormone, and aluminium in chronic renal failure.
    Biswas CK; Arze RS; Ramos JM; Ward MK; Dewar JH; Kerr DN; Kenward DH
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):776-8. PubMed ID: 6802224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk/benefit in prophylaxis and treatment of secondary hyperparathyroidism. A comparison of two low calcium peritoneal dialysis fluids.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996; 11 Suppl 3():47-9. PubMed ID: 8840312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.